Skip to main content
SpringerLink
Log in

Adrenomedullin expression does not correlate with survival in lung cancer

  • Origanal Article
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

It is suggested that adrenomedullin (AM) plays a role in lung carcinogenesis although, to confirm this suggestion, further clinical studies are needed to determine its relationship with prognosis in lung cancer. Archived 50 paraffin-embedded tumor samples of the lung were retrospectively evaluated for AM expression by immunohistochemistry and analyzed for a possible correlation with patient characteristics and survival. Quantitation of immunoreactivity was accomplished using an immunohistochemical scoring system. The pulmonary resection specimens contained 22 squamous cell carcinomas, 15 adenocarcinomas, and 13 small cell carcinomas. Non-small cell carcinomas of the lung were more likely to express AM than small cell carcinomas of the lung. Ninety-one percent of squamous cell carcinomas and 87% of adenocarcinomas expressed AM at a moderate to strong level and grade2–4 (30-100%), which were significantly higher from the non-neo-plastic lung tissue. Twenty-three percent of small cell carcinomas of lung expressed AM. Interestingly, AM immunoreactivity was essentially weak and grade 1 (<%30) in this group. AM expression is upregulated in non-small cell carcinomas of the lung, whereas it is downregulated in small cell carcinomas and non-neo-plastic lung tissues. AM expression did not show any correlation with the differentiation of the tumor, the stage of cancer, and the overall survival of patients. These results did not support the role of adrenomedullin as an independent survival factor for lung cancer. However, AM inhibition in conjunction with other anti-angiogenic agents may be useful in the prevention and treatment of malignancies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kitamura K., et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma.Biochem Biophys Res Commun 1993;192:553–560.

    Article  PubMed  CAS  Google Scholar 

  2. Ishiyama Y., et al. Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin in rats.Eur J Pharmacol 1993;241:271–273.

    Article  PubMed  CAS  Google Scholar 

  3. Kitamura K, Sakata J, Kangawa K, Kojima M, Matsuo H, Eto T: Cloning and characterization of cDNA encoding a precursor for adrenomedullin.Biochem Biophys Res Commun 1993;194:720–725.

    Article  PubMed  CAS  Google Scholar 

  4. Kato H, Shichiri M, Marumo F, Hirata Y. Adrenomedullin as an autocrine/paracrine apoptosis survival factor for rat endothelial cells.Endocrinology 1997;138:2615–2620.

    Article  PubMed  CAS  Google Scholar 

  5. Cormier-Regard S, Nguyen SV, Claycomb WC. Adreno-medullin gene expression is developmentally regulated and induced by hypoxia in rat ventricular cardiac myocytes.J BiolChem 1998;273:17787–17792.

    CAS  Google Scholar 

  6. Garayoa M, et al. Hypoxia-inducible factor-1 (HIF-1) upregulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: a possible promotion mechanism of carcinogenesis.Mol Endocrinol 2000;41:848–862.

    Article  Google Scholar 

  7. Iwasaki H, Eguchi S, Shichiri M, Marumo F, Hirata Y. Adrenomedullin as a novel growth-promoting factor for cultured vascular smooth muscle cells: role of tyrosine kinase-mediated mitogen-activated protein kinase activa-tion.Endocrinology 1998;139:3432–3441.

    Article  PubMed  CAS  Google Scholar 

  8. Hague S, et al. Expression of the hypoxically regulated angiogenic factor adrenomedullin correlates with uterine leiomyoma vascular density.Clin Cancer Res 2000;6:2808–2814.

    PubMed  CAS  Google Scholar 

  9. Kitamuro T, et al. Induction of adrenomedullin during hypoxia in cultured human glioblastoma cells.J Neurochem 2000;75:1826–1833.

    Article  PubMed  CAS  Google Scholar 

  10. Miller MJ, et al. Adrenomedullin expression in human tumor cell lines: its potential role as an autocrine growth factor.J Biol Chem 1996;271:23345–23351.

    Article  PubMed  CAS  Google Scholar 

  11. Ehlenz K, Koch B, Preuss P, Simon B, Koop I, Lang RE. High levels of circulating adrenomedullin in severe illness: correlation with C-reactive protein and evidence against the adrenal medulla as site of origin.Exp Clin Endocrinol Diabetes 1997;105:156–162.

    PubMed  CAS  Google Scholar 

  12. Martinez A, Miller MJ, Catt KJ, Cuttitta F. Adrenomedullin receptor expression in human lung and in pulmonary tumors.J Histochem Cytochem 1997;45:159–164.

    PubMed  CAS  Google Scholar 

  13. Martinez A, Miller MJ, Unsworth EJ, Siegfried JM, Cuttitta F. Expression of adrenomedullin in normal human lung and in pulmonary tumors.Endocrinology 1995;136:4099–4105.

    Article  PubMed  CAS  Google Scholar 

  14. Cuttitta F, et al. The role of adrenomedullin as a growth regulatory peptide in the normal and malignant setting.JAnim Sci 1999;77:55–69.

    Google Scholar 

  15. Cuttitta F, et al. Adrenomedullin functions as an important tumor survival factor in human carcinogenesis.Microsc Res Tech 2002;57:110–119.

    Article  PubMed  CAS  Google Scholar 

  16. Oehler MK, Hague S, Rees MCP, Bicknell R. Adrenomedullin promotes formation of xenografted endometrial tumors by stimulation of autocrine growth and angiogenesis.Oncogene 2002;21:2815–2821.

    Article  PubMed  CAS  Google Scholar 

  17. Oehler MK, Norbury C, Hague S, Rees MC, Bicknell R. Adrenomedullin inhibits hypoxic cell death by upregulation of Bcl-2 in endometrial cancer cells: a possible promotion mechanism for tumour growth.Oncogene 2001 ;2b0: 2937–2945.

    Article  Google Scholar 

  18. Rocchi P, et al. Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines.Cancer Res 2001;61:1196–1206.

    PubMed  CAS  Google Scholar 

  19. Ouafik L, et al. Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo.Am J Pathol 2002;160:1279–1292.

    PubMed  CAS  Google Scholar 

  20. Hata K, et al. Expression of the adrenomedullin gene in epithelial ovarian cancer.Mol Hum Reprod 2000;6:867–872.

    Article  PubMed  CAS  Google Scholar 

  21. Liu J, Kahri AI, Heikkila P, Voutilainen R. Adrenomedullin gene expression and its different regulation in human adrenocortical and medullary tumors.J Endocrinol 1997;155:483–490.

    Article  PubMed  CAS  Google Scholar 

  22. Martinez A, et al. Expression of adrenomedullin and its receptor in normal and malignant human skin: a potential pluripotent role in the integument.Endocrinology 1997;138:5597–5604.

    Article  PubMed  CAS  Google Scholar 

  23. Satoh F, et al. Adrenomedullin in human brain, adrenal glands and tumor tissues of pheochromocytoma, ganglioneuroblastoma and neuroblastoma.J Clin Endocrinol Metab 1995;80:1750–1752.

    Article  PubMed  CAS  Google Scholar 

  24. Nishikimi T, et al. Clinical studies on the sites of production and clearance of circulating adrenomedullin in human subjects.Hypertension 1994;24:600–604.

    PubMed  CAS  Google Scholar 

  25. Martinez A, et al. The effects of adrenomedullin overexpression in breast tumor cells.J Natl Cancer Inst 2002;94: 1226–1237.

    PubMed  CAS  Google Scholar 

  26. Zhong H, et al. Overexpression of hypoxia-inducible factor-1 in common human cancers and their metastases.Cancer Res 1999;59:5830–5835.

    PubMed  CAS  Google Scholar 

  27. Birner P, Schindl M, Obermair A, Plank C, Breitenecker G, Oberhuber G. Overexpression of hypoxia-inducible factor 1 alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer.Cancer Res 2000;60:4693–4696.

    PubMed  CAS  Google Scholar 

  28. Semenza GL. Regulation of mammalian Q2 homeostasis by hypoxia-inducible factor 1.Annu Rev Cell Dev Biol 1999;15:551–578.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Oncology, Gazi University, Medical Faculty, Gazi Hospital, 06500, Ankara

    S. Buyukberber (Prof. Dr.)

  2. Departments of Pathology, Gaziantep University, Medical Faculty, 27100, Gaziantep, Turkey

    I. Sari

  3. Medical Oncology, Gaziantep University, Medical Faculty, 27100, Gaziantep, Turkey

    C. Camci, A. Sevinc & H. M. Turk

  4. Internal Medicine, Gaziantep University, Medical Faculty, 27100, Gaziantep, Turkey

    N. M. Buyukberber

Authors
  1. S. Buyukberber
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. Sari
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Camci
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N. M. Buyukberber
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Sevinc
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. H. M. Turk
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Buyukberber.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Buyukberber, S., Sari, I., Camci, C. et al. Adrenomedullin expression does not correlate with survival in lung cancer. Med Oncol 24, 245–249 (2007). https://doi.org/10.1007/BF02698047

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02698047

Key words

Search

Navigation